XML 13 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Balance Sheets (Parenthetical) - USD ($)
shares in Thousands, $ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Net investment in sales-type leases, allowances $ 907 $ 465
Ground Lease receivables, allowances 692 369
Loans receivable, net - related party, allowances $ 2,392 $ 2,429
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 400,000 400,000
Common stock, shares issued (in shares) 71,435 71,077
Common stock, shares outstanding (in shares) 71,435 71,077
Deferred expenses and other assets, net [1],[2] $ 124,877 $ 89,238
Related party    
Deferred expenses and other assets, net $ 6,600 $ 7,100
[1] As of March 31, 2024 and December 31, 2023, includes $6.6 million and $7.1 million, respectively, due from related parties.
[2] Refer to Note 2 for details on the Company’s consolidated variable interest entities (“VIEs”).